Delivery Order W81K0219D0011-W81K0223F0093
Award Date 9/29/23
Potential Completion Date 9/28/24
Potential Value $45K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
South Korea
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of the Army Medical Command awarded a $37,989.49 firm fixed price delivery order to Perkinelmer Genetics, Inc. for newborn screening testing services at Brian D. Allgood Army Community Hospital/121st Combat Support Hospital in Korea. As the prime contractor, Perkinelmer Genetics will provide these services from September 2020 through September 2021 in support of the hospital's newborn screening program. Perkinelmer Genetics is a subsidiary of Revvity Inc., which focuses on medical...
- The Defense Health Agency awarded Revvity Omics Inc., operating as Perkinelmer Genetics, a $42,993 delivery order for newborn screening testing services at Brian D. Allgood Army Community Hospital in South Korea. This firm fixed-price contract, awarded on September 29, 2025, is scheduled for completion by September 28, 2026, and operates under a larger single-award indefinite delivery contract vehicle valued at $301,668 with a performance period extending through September 2029. The delivery...
- The Defense Health Agency awarded a $40,945.50 firm fixed-price delivery order to Revvity Omics Inc. (doing business as Perkinelmer Genetics) on September 29, 2024, for newborn screening testing services at Brian D. Allgood Army Community Hospital (BDAACH) in South Korea. This task order covers the base performance period from September 29, 2024, through September 28, 2025, and was awarded without a small business set-aside designation. The delivery order is issued under a larger single-award...
- Revvity Omics Inc., operating as Perkinelmer Genetics, received a $4,549.50 firm fixed-price delivery order from the Defense Health Agency for newborn screening testing services at Brian D. Allgood Army Community Hospital in South Korea. This delivery order, awarded on July 1, 2025, with completion scheduled for September 28, 2025, represents a task order issued under Revvity Omics Inc.'s larger Indefinite Delivery Contract valued at $301,668 and awarded to the same facility on September 29,...
- The Department of the Army Medical Command awarded a firm fixed price delivery order valued at thirty-three thousand eight hundred eighty dollars to Perkinelmer Genetics, Inc. to provide newborn screening testing services for Brian Allgood Community Hospital and the one hundred twenty-first Combat Support Hospital in Korea under the base period from September twenty-nine, two thousand nineteen through September twenty-eight, two thousand twenty. The order was issued off an unidentified medical...
- This delivery order against the Defense Health Agency's Newborn Screening Testing Services contract awards Perkinelmer Genetics, Inc. $8,918.84 to provide newborn screening testing services for the Brian D. Allgood Army Community Hospital in South Korea from June 1, 2023 through September 28, 2023. As the prime contractor, Perkinelmer Genetics will perform the testing at its own facilities, with oversight from the Defense Health Agency. The contract has no set-aside designation and utilizes a...
- The Department of the Army Medical Command awarded a $45,092.88 firm fixed price delivery order to Perkinelmer Genetics, Inc. of Pittsburgh, Pennsylvania for newborn screening testing services in support of Brian D. Allgood Army Community Hospital and the 121st Combat Support Hospital in Korea. As the prime contractor, Perkinelmer Genetics will provide newborn screening to be performed at its laboratory in Pittsburgh on samples collected at the Army medical treatment facilities. The testing...
- This is a firm fixed price contract awarded by the U.S. Department of Defense's Medical Command (MEDCOM) to Revvity Omics Inc., doing business as Perkinelmer Genetics, for $91,840.00. The contract is for newborn screening services, which involves testing infants for conditions such as galactosemia, hypothyroidism, sickle cell disease, and cystic fibrosis. Perkinelmer Genetics is the prime contractor and does not appear to have any major subcontractors. This contract is not associated with a...
- The Department of the Army Medical Command awarded a Firm Fixed Price Blanket Purchase Agreement (BPA) call to Perkinelmer Genetics, Inc., a for-profit organization, to provide newborn screening tests. The contract has a potential value of $143,440.00 and a performance period ending on September 30, 2018. Perkinelmer Genetics, a subsidiary of Revvity Inc., specializes in newborn and genetic screening services, and has provided similar testing support to military hospitals and treatment...
- This contract was awarded by the U.S. Department of the Army Medical Command to Perkinelmer Genetics, Inc., a for-profit medical services provider, to conduct newborn screening testing. The contract has a firm fixed price of $148,000.00 and a completion date of September 30, 2020. Perkinelmer Genetics, a subsidiary of the parent company Revvity Inc., specializes in newborn and genetic screening services to support military hospitals and treatment facilities in the U.S. and overseas. This...